These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35720334)
1. Guo X; Mao X; Tian D; Liao Y; Su B; Ye C; Shi D; Liu TF; Ling Y; Hao Y Front Immunol; 2022; 13():872286. PubMed ID: 35720334 [No Abstract] [Full Text] [Related]
3. Invasive fungal infection by Cryptococcus neoformans var. grubii with bone marrow and meningeal involvement in a HIV-infected patient: a case report. Vechi HT; Theodoro RC; de Oliveira AL; Gomes RMODS; Soares RDA; Freire MG; Bay MB BMC Infect Dis; 2019 Mar; 19(1):220. PubMed ID: 30832607 [TBL] [Abstract][Full Text] [Related]
4. Role of capsule and interleukin-6 in long-term immune control of Cryptococcus neoformans infection by specifically activated human peripheral blood mononuclear cells. Siddiqui AA; Shattock RJ; Harrison TS Infect Immun; 2006 Sep; 74(9):5302-10. PubMed ID: 16926424 [TBL] [Abstract][Full Text] [Related]
5. Role of CD4+ T cells in a protective immune response against Cryptococcus neoformans in the central nervous system. Uicker WC; McCracken JP; Buchanan KL Med Mycol; 2006 Feb; 44(1):1-11. PubMed ID: 16805087 [TBL] [Abstract][Full Text] [Related]
6. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835 [TBL] [Abstract][Full Text] [Related]
7. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. Wozniak KL; Ravi S; Macias S; Young ML; Olszewski MA; Steele C; Wormley FL PLoS One; 2009 Sep; 4(9):e6854. PubMed ID: 19727388 [TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognostic factors of 60 patients with acquired immune deficiency syndrome combined with Cryptococcus neoformans. Liu S; Chen W; Cheng F; Ye X; Pan N; Lu H BMC Infect Dis; 2023 Apr; 23(1):204. PubMed ID: 37024795 [TBL] [Abstract][Full Text] [Related]
10. [Cryptococcosis caused by Cryptococcus neoformans var. Gattii. A case associated with acquired immunodeficiency syndrome (AIDS) in Kinshasa, Zaire]. Muyembe Tamfum JJ; Mupapa Kibadi D; Nganda L; Ngwala-Bikindu D; Kuezina T; Kela-We I; Vandepitte J Med Trop (Mars); 1992; 52(4):435-8. PubMed ID: 1494313 [TBL] [Abstract][Full Text] [Related]
11. Requirement for CD4(+) T lymphocytes in host resistance against Cryptococcus neoformans in the central nervous system of immunized mice. Buchanan KL; Doyle HA Infect Immun; 2000 Feb; 68(2):456-62. PubMed ID: 10639404 [TBL] [Abstract][Full Text] [Related]
12. The F-Box Protein Fbp1 Shapes the Immunogenic Potential of Masso-Silva J; Espinosa V; Liu TB; Wang Y; Xue C; Rivera A mBio; 2018 Jan; 9(1):. PubMed ID: 29317510 [No Abstract] [Full Text] [Related]
13. Comparison of clinical and biological characteristics of HIV-infected patients presenting Cryptococcus neoformans versus C. curvatus/C. laurentii meningitis. Zono B; Moutschen M; Situakibanza H; Sacheli R; Muendele G; Kabututu P; Biakabuswa A; Landu N; Mvumbi G; Hayette MP BMC Infect Dis; 2021 Nov; 21(1):1157. PubMed ID: 34781895 [TBL] [Abstract][Full Text] [Related]
14. Resistance and Tolerance to Cryptococcal Infection: An Intricate Balance That Controls the Development of Disease. Shourian M; Qureshi ST Front Immunol; 2019; 10():66. PubMed ID: 30761136 [No Abstract] [Full Text] [Related]
15. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole. Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338 [TBL] [Abstract][Full Text] [Related]
16. Fungal CNS Infections in Africa: The Neuroimmunology of Cryptococcal Meningitis. Mohamed SH; Nyazika TK; Ssebambulidde K; Lionakis MS; Meya DB; Drummond RA Front Immunol; 2022; 13():804674. PubMed ID: 35432326 [TBL] [Abstract][Full Text] [Related]
17. Cryptococcosis in the era of AIDS--100 years after the discovery of Cryptococcus neoformans. Mitchell TG; Perfect JR Clin Microbiol Rev; 1995 Oct; 8(4):515-48. PubMed ID: 8665468 [TBL] [Abstract][Full Text] [Related]
18. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain. Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849 [TBL] [Abstract][Full Text] [Related]
19. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. Saijo T; Chen J; Chen SC; Rosen LB; Yi J; Sorrell TC; Bennett JE; Holland SM; Browne SK; Kwon-Chung KJ mBio; 2014 Mar; 5(2):e00912-14. PubMed ID: 24643864 [TBL] [Abstract][Full Text] [Related]
20. Cryptococcus neoformans meningitis in the rat. Goldman DL; Casadevall A; Cho Y; Lee SC Lab Invest; 1996 Dec; 75(6):759-70. PubMed ID: 8973471 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]